Description

[1-(1,1-Dioxidotetrahydro-3-Thienyl)-3,5-Dimethyl-1H-Pyrazol-4-Yl]Acetic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its unique sulfone and pyrazole acetic acid structure. This compound is of significant commercial value for the synthesis of novel active pharmaceutical ingredients (APIs) targeting specific therapeutic pathways. It is primarily required by research institutions and pharmaceutical manufacturers engaged in the development of new chemical entities, particularly for anti-inflammatory and metabolic disorder applications.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly those targeting inflammation and metabolic diseases.
• Biochemical Research: Used as a reference standard or reagent in proteomics and enzyme inhibition studies due to its specific molecular scaffold.
• Medicinal Chemistry: Serves as a core structure for the development and optimization of new chemical libraries for high-throughput screening.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and scale-up of complex organic molecules for clinical trials.

Basic Information

Product Name	[1-(1,1-Dioxidotetrahydro-3-Thienyl)-3,5-Dimethyl-1H-Pyrazol-4-Yl]Acetic Acid
CAS No.	926235-14-5
Molecular Formula	C11H16N2O4S
Molecular Weight	272.32 g/mol
Synonyms	4-Carboxymethyl-3,5-dimethyl-1-(tetrahydro-3-thienylsulfonyl)pyrazole; 2-[3,5-Dimethyl-1-(1,1-dioxo-1λ⁶-thiolan-3-yl)-1H-pyrazol-4-yl]acetic Acid; (3,5-Dimethyl-1-(tetrahydrothiophene-3-sulfonyl)-1H-pyrazol-4-yl)acetic Acid; 1-(1,1-Dioxotetrahydro-3-thienyl)-3,5-dimethyl-1H-pyrazole-4-acetic Acid; 926235-14-5; Tetrahydrothiophene-3-sulfonic acid 3,5-dimethyl-4-carboxymethylpyrazolide
EINECS	Contact for details

Quality Control

Our production of [1-(1,1-Dioxidotetrahydro-3-Thienyl)-3,5-Dimethyl-1H-Pyrazol-4-Yl]Acetic Acid adheres to stringent quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and MS, to ensure it meets the exacting standards required for pharmaceutical R&D. Certificates of Analysis (COA) with full traceability are provided for all shipments.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). The product is moisture-sensitive; keep the container tightly sealed under inert atmosphere for long-term storage to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.